• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

微小RNA-335-5p和-3p协同作用抑制雌激素受体α表达并促进他莫昔芬耐药。

MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance.

作者信息

Martin Elizabeth C, Conger Adrienne K, Yan Thomas J, Hoang Van T, Miller David F B, Buechlein Aaron, Rusch Douglas B, Nephew Kenneth P, Collins-Burow Bridgette M, Burow Matthew E

机构信息

Department of Biological and Agricultural Engineering, Louisiana State University and LSU Agricultural Center, Baton Rouge, LA, USA.

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

FEBS Lett. 2017 Jan;591(2):382-392. doi: 10.1002/1873-3468.12538. Epub 2017 Jan 12.

DOI:10.1002/1873-3468.12538
PMID:28008602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5853108/
Abstract

microRNAs (miRNAs) are small noncoding RNA molecules involved in the regulation of gene expression and play critical roles in human malignancies. Next-generation sequencing analysis of the MCF-7 breast cancer cell line overexpressing miR-335-5p and miR-335-3p demonstrated that the miRNA duplex repressed genes involved in the ERα signaling pathway, and enhanced resistance of MCF-7 cells to the growth inhibitory effects of tamoxifen. These data suggest that despite its conventional role in tumor suppression, the miR-335 transcript can also play an oncogenic role in promoting agonistic estrogen signaling in a cancerous setting.

摘要

微小RNA（miRNA）是参与基因表达调控的小型非编码RNA分子，在人类恶性肿瘤中发挥关键作用。对过表达miR-335-5p和miR-335-3p的MCF-7乳腺癌细胞系进行的下一代测序分析表明，该miRNA双链体抑制了参与雌激素受体α（ERα）信号通路的基因，并增强了MCF-7细胞对他莫昔芬生长抑制作用的抗性。这些数据表明，尽管miR-335转录本在肿瘤抑制中具有传统作用，但在癌性环境中，它也可能在促进雌激素激动信号传导方面发挥致癌作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8772/5853108/d6914bbee295/nihms839506f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8772/5853108/0fd2ea3073ab/nihms839506f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8772/5853108/0f632d43cb87/nihms839506f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8772/5853108/42c48f6e3633/nihms839506f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8772/5853108/e5fb4829ae6a/nihms839506f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8772/5853108/1c42b3ac803f/nihms839506f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8772/5853108/d6914bbee295/nihms839506f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8772/5853108/0fd2ea3073ab/nihms839506f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8772/5853108/0f632d43cb87/nihms839506f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8772/5853108/42c48f6e3633/nihms839506f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8772/5853108/e5fb4829ae6a/nihms839506f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8772/5853108/1c42b3ac803f/nihms839506f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8772/5853108/d6914bbee295/nihms839506f6.jpg

相似文献

1
MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance.微小RNA-335-5p和-3p协同作用抑制雌激素受体α表达并促进他莫昔芬耐药。
FEBS Lett. 2017 Jan;591(2):382-392. doi: 10.1002/1873-3468.12538. Epub 2017 Jan 12.
2
Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.微小RNA-27b-3p的下调通过增加NR5A2和CREB1的表达增强乳腺癌对他莫昔芬的耐药性。
Cell Death Dis. 2016 Nov 3;7(11):e2454. doi: 10.1038/cddis.2016.361.
3
The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.ERα-miR-575-p27 反馈环路调节 ER 阳性乳腺癌对他莫昔芬的敏感性。
Theranostics. 2020 Aug 29;10(23):10729-10742. doi: 10.7150/thno.46297. eCollection 2020.
4
miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer.参与LY6K和雌激素受体α的微小RNA有助于乳腺癌对他莫昔芬的敏感性。
Oncotarget. 2016 Jul 5;7(27):42261-42273. doi: 10.18632/oncotarget.9950.
5
miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor-positive breast cancer.miR-125a-3p 通过靶向 CDK3 抑制 ERα 转录激活并克服雌激素受体阳性乳腺癌中的他莫昔芬耐药性。
FASEB J. 2018 Feb;32(2):588-600. doi: 10.1096/fj.201700461RR. Epub 2018 Jan 4.
6
Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation.雌激素受体下调 microRNA-515-5p 调节鞘氨醇激酶 1 和乳腺癌细胞增殖。
Cancer Res. 2013 Oct 1;73(19):5936-48. doi: 10.1158/0008-5472.CAN-13-0158. Epub 2013 Aug 8.
7
Loss of Estrogen-Regulated at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer.雌激素调节基因 at 3p21.1 的缺失促进乳腺癌对他莫昔芬的耐药性。
Cancer Res. 2018 Sep 1;78(17):4915-4928. doi: 10.1158/0008-5472.CAN-18-0069. Epub 2018 Jun 26.
8
Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression.榄香烯通过重新表达雌激素受体 α（ERα）逆转 MCF-7 细胞对他莫昔芬耐药性的研究。
Breast Cancer Res Treat. 2012 Nov;136(2):399-406. doi: 10.1007/s10549-012-2263-6. Epub 2012 Sep 30.
9
Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cells.基于生物信息学的 miR-92a-3p 与他莫昔芬耐药乳腺癌细胞中关键基因相互作用分析。
Biomed Pharmacother. 2018 Nov;107:117-128. doi: 10.1016/j.biopha.2018.07.158. Epub 2018 Aug 4.
10
MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer.微小RNA-221/222负向调节雌激素受体α，并与乳腺癌的他莫昔芬耐药相关。
J Biol Chem. 2008 Nov 7;283(45):31079-86. doi: 10.1074/jbc.M806041200. Epub 2008 Sep 12.

引用本文的文献

1
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.将表观遗传调节因子作为克服癌症治疗耐药性的一条有前景的途径。
Signal Transduct Target Ther. 2025 Jul 18;10(1):219. doi: 10.1038/s41392-025-02266-z.
2
The Role of Heavy Metals in the Biology of Female Cancers.重金属在女性癌症生物学中的作用。
Int J Mol Sci. 2025 May 28;26(11):5155. doi: 10.3390/ijms26115155.
3
Exosome-Mediated Cellular Communication in the Tumor Microenvironment Imparts Drug Resistance in Breast Cancer.外泌体介导的肿瘤微环境中的细胞通讯赋予乳腺癌耐药性。

本文引用的文献

1
Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.微小RNA-200b-3p和微小RNA-200b-5p对三阴性乳腺癌上皮-间质转化抑制的双重调控
Oncotarget. 2015 Jun 30;6(18):16638-52. doi: 10.18632/oncotarget.3184.
2
Endocrine resistance in breast cancer: Current status and a perspective on the roles of miRNAs (Review).乳腺癌中的内分泌耐药：现状及微小RNA作用的展望（综述）
Oncol Lett. 2013 Aug;6(2):295-305. doi: 10.3892/ol.2013.1405. Epub 2013 Jun 17.
3
The UCSC Cancer Genomics Browser: update 2013.
Cancers (Basel). 2025 Mar 30;17(7):1167. doi: 10.3390/cancers17071167.
4
miRNA-dependent resistance mechanisms to anti-hormonal therapies in estrogen receptor-positive breast cancer patients.雌激素受体阳性乳腺癌患者中miRNA依赖的抗激素治疗耐药机制
Mol Ther Oncol. 2025 Jan 28;33(1):200941. doi: 10.1016/j.omton.2025.200941. eCollection 2025 Mar 20.
5
Transcription factors and hormone receptors: Sex‑specific targets for cancer therapy (Review).转录因子与激素受体：癌症治疗的性别特异性靶点（综述）
Oncol Lett. 2024 Dec 6;29(2):93. doi: 10.3892/ol.2024.14839. eCollection 2025 Feb.
6
miR-205 Regulates Tamoxifen Resistance by Targeting Estrogen Receptor Coactivator MED1 in Human Breast Cancer.miR-205通过靶向雌激素受体共激活因子MED1调控人乳腺癌中他莫昔芬耐药性。
Cancers (Basel). 2024 Nov 28;16(23):3992. doi: 10.3390/cancers16233992.
7
Cellular and Exosomal MicroRNAs: Emerging Clinical Relevance as Targets for Breast Cancer Diagnosis and Prognosis.细胞和外泌体 microRNAs：作为乳腺癌诊断和预后靶点的临床新关联。
Adv Biol (Weinh). 2024 Apr;8(4):e2300532. doi: 10.1002/adbi.202300532. Epub 2024 Jan 22.
8
Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer.非编码RNA对乳腺癌雌激素信号传导及内分泌治疗反应的调控
Cancers (Basel). 2023 Mar 7;15(6):1632. doi: 10.3390/cancers15061632.
9
Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies.抗雌激素治疗耐药性的分子机制及新型靶向治疗
Cancers (Basel). 2022 Oct 24;14(21):5206. doi: 10.3390/cancers14215206.
10
The role of exosomal microRNAs; focus on clinical applications in breast cancer.外泌体微小RNA的作用；聚焦于在乳腺癌中的临床应用
Cancer Drug Resist. 2019 Sep 19;2(3):847-861. doi: 10.20517/cdr.2019.17. eCollection 2019.
UCSC 癌症基因组浏览器：2013 年更新。
Nucleic Acids Res. 2013 Jan;41(Database issue):D949-54. doi: 10.1093/nar/gks1008. Epub 2012 Oct 29.
4
Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells.pre-miR-24-2 靶标 PKC-α 的优先星链生物发生，并抑制 MCF-7 乳腺癌细胞中的细胞存活。
Mol Carcinog. 2014 Jan;53(1):38-48. doi: 10.1002/mc.21946. Epub 2012 Aug 21.
5
Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer.miRNA-375 的再表达逆转了乳腺癌的他莫昔芬耐药性和伴随的 EMT 样特性。
Oncogene. 2013 Feb 28;32(9):1173-82. doi: 10.1038/onc.2012.128. Epub 2012 Apr 16.
6
A positive cross-regulation of HER2 and ER-α36 controls ALDH1 positive breast cancer cells.HER2 和 ER-α36 的正交叉调控控制着 ALDH1 阳性乳腺癌细胞。
J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):262-8. doi: 10.1016/j.jsbmb.2011.08.011. Epub 2011 Sep 3.
7
Cracking the estrogen receptor's posttranslational code in breast tumors.破解乳腺癌肿瘤中雌激素受体的翻译后密码。
Endocr Rev. 2011 Oct;32(5):597-622. doi: 10.1210/er.2010-0016. Epub 2011 Jun 15.
8
MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development.微小 RNA miR-335 对乳腺癌发展中 BRCA1 调控级联反应至关重要。
Int J Cancer. 2011 Dec 15;129(12):2797-806. doi: 10.1002/ijc.25962. Epub 2011 May 25.
9
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors.miR-342 的下调与他莫昔芬耐药的乳腺癌肿瘤有关。
Mol Cancer. 2010 Dec 20;9:317. doi: 10.1186/1476-4598-9-317.
10
The UCSC Cancer Genomics Browser: update 2011.加州大学圣克鲁兹分校癌症基因组浏览器：2011年更新版
Nucleic Acids Res. 2011 Jan;39(Database issue):D951-9. doi: 10.1093/nar/gkq1113. Epub 2010 Nov 8.